Status: Recruiting
Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD)
The main objective of the study is evaluation of the safety and tolerability of RPESC-RPE-4W as therapy for dry AMD.
Participants needed: 18
Trial details
Phase: Phase 1, Phase 2Age: 55+Biological sex: AllType: InterventionalSponsor: Luxa Biotechnology, LLCUpdated: Oct 15, 2025Locations: 3
Eligibility criteria
Clinical diagnosis of dry AMD. [+5]
Allergy or hypersensitivity to dilation drops or fluorescein. [+7]